Evidence map›Paper›PMID 41646132›Full record

ArticleiGIE : innovation, investigation and insights2024

Artificial intelligence-based skeletal muscle estimates and outcomes of EUS-guided treatment of pancreatic fluid collections.

Mamoru Takenaka, Wataru Gonoi, Tatsuya Sato, Tomotaka Saito, Shouhei Hanaoka, Tsuyoshi Hamada, Shunsuke Omoto, Atsuhiro Masuda, Masahiro Tsujimae, Takuji Iwashita and 17 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in iGIE : innovation, investigation and insights, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Immediate Endoscopic Necrosectomy for Walled-Off Pancreatic Necrosis: A First-Choice Option?Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Mamoru TakenakaDepartment of Gastroenterology and Hepatology, Faculty of Medicine, Kindai University, Osaka, Japan.
Wataru GonoiDepartment of Radiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Tatsuya SatoDepartment of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Tomotaka SaitoDepartment of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Shouhei HanaokaDepartment of Radiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Tsuyoshi HamadaDepartment of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Shunsuke OmotoDepartment of Gastroenterology and Hepatology, Faculty of Medicine, Kindai University, Osaka, Japan.
Atsuhiro MasudaDivision of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Hyogo, Japan.
Masahiro TsujimaeDivision of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Hyogo, Japan.
Takuji IwashitaFirst Department of Internal Medicine, Gifu University Hospital, Gifu, Japan.
Shinya UemuraFirst Department of Internal Medicine, Gifu University Hospital, Gifu, Japan.
Shogo OtaDivision of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Hyogo, Japan.
Hideyuki ShiomiDivision of Hepatobiliary and Pancreatic Diseases, Department of Gastroenterology, Hyogo Medical University, Hyogo, Japan.
Toshio FujisawaDepartment of Gastroenterology, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
Sho TakahashiDepartment of Gastroenterology, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
Saburo MatsubaraDepartment of Gastroenterology and Hepatology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Kentaro SudaDepartment of Gastroenterology and Hepatology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Akinori MarutaDepartment of Gastroenterology, Gifu Prefectural General Medical Center, Gifu, Japan.
Kensaku YoshidaDepartment of Gastroenterology, Gifu Prefectural General Medical Center, Gifu, Japan.
Keisuke IwataDepartment of Gastroenterology, Gifu Municipal Hospital, Gifu, Japan.
Mitsuru OkunoDepartment of Gastroenterology, Gifu Municipal Hospital, Gifu, Japan.
Nobuhiko HayashiThird Department of Internal Medicine, University of Toyama, Toyama, Japan.
Tsuyoshi MukaiDepartment of Gastroenterological Endoscopy, Kanazawa Medical University, Ishikawa, Japan.
Hiroyuki IsayamaDepartment of Gastroenterology, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
Ichiro YasudaThird Department of Internal Medicine, University of Toyama, Toyama, Japan.
Yousuke NakaiDepartment of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
WONDERFUL study group in Japan and collaborators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: Skeletal muscle status may affect clinical outcomes of a variety of pancreatic diseases. Skeletal muscle quality and quantity have not been fully examined in relation to the outcomes of EUS-guided treatment of pancreatic fluid collections (PFCs). Methods: Using a multi-institutional cohort of 372 patients receiving EUS-guided treatment of PFCs in 2010 to 2020, we examined the association of skeletal muscle status with adverse outcomes, including clinical treatment failure and in-hospital mortality. We used an in-house deep learning-based platform for preprocedural CT images, and skeletal muscle density (SMD) and skeletal muscle index (SMI; height-adjusted muscle area) were calculated as surrogates for muscular quality and quantity, respectively. Multivariable logistic regression analysis was conducted to calculate odds ratios (ORs) for adverse outcomes. Results: Lower-level SMD was associated with higher risks of clinical failure and in-hospital mortality ( Conclusions: In patients with endoscopically managed PFCs, SMD (but not SMI) was associated with the risks of clinical failure and in-hospital mortality, supporting the prognostic role of skeletal muscle quality.

Identifiers

PMID41646132
PMCPMC12850727

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.